322 related articles for article (PubMed ID: 11362921)
21. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
22. [Antiretroviral treatment. Present and future of the combinations].
Gatell-Artigas JM
Rev Neurol; 1996 Dec; 24(136):1627-31. PubMed ID: 9064189
[TBL] [Abstract][Full Text] [Related]
23. Researchers are rethinking role of AZT in drug therapy.
AIDS Policy Law; 1995 Oct; 10(18):11. PubMed ID: 11362821
[TBL] [Abstract][Full Text] [Related]
24. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
25. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
26. Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference.
Torres G
GMHC Treat Issues; 1996 Sep; 10(9):7, 10-1. PubMed ID: 11363842
[TBL] [Abstract][Full Text] [Related]
27. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
Cooper EC
AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
[TBL] [Abstract][Full Text] [Related]
28. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
29. Update on clinical trials of combination therapies for HIV infection.
NIAID AIDS Agenda; 1995 Sep; ():8. PubMed ID: 11362803
[TBL] [Abstract][Full Text] [Related]
30. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
31. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
[No Abstract] [Full Text] [Related]
32. CPCRA 007: preliminary results of combination antiretroviral study.
Randall P
NIAID AIDS Agenda; 1996 Mar; ():2. PubMed ID: 11363796
[TBL] [Abstract][Full Text] [Related]
33. 3TC: combination trial stopped early as clinical benefit shown.
James JS
AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
[TBL] [Abstract][Full Text] [Related]
34. Confirmation for combination AIDS therapy.
Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948
[No Abstract] [Full Text] [Related]
35. Major study shows AZT monotherapy inferior.
James JS
AIDS Treat News; 1995 Sep; (no 231):3-4. PubMed ID: 11362867
[TBL] [Abstract][Full Text] [Related]
36. Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality.
Stephenson J
JAMA; 1995 Oct; 274(15):1183-4. PubMed ID: 7563492
[No Abstract] [Full Text] [Related]
37. Data and safety monitoring in the Delta trial.
Armitage P
Control Clin Trials; 1999 Jun; 20(3):229-41. PubMed ID: 10357496
[TBL] [Abstract][Full Text] [Related]
38. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
39. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
James JS
AIDS Treat News; 1995 Dec; (no 236):7. PubMed ID: 11363052
[TBL] [Abstract][Full Text] [Related]
40. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
Saravolatz LD; Winslow DL; Collins G; Hodges JS; Pettinelli C; Stein DS; Markowitz N; Reves R; Loveless MO; Crane L; Thompson M; Abrams D
N Engl J Med; 1996 Oct; 335(15):1099-106. PubMed ID: 8813040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
